microbiome

Takeda joins microbiome-focused biotech partner's $52.6M raise as it pursues more in-house cancer work
Takeda joins microbiome-focused biotech partner's $52.6M raise as it pursues more in-house cancer work
Endpoints
Takeda
Enterome
microbiome
R&D
Flag link:
Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact
Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact
Fierce Biotech
Assembly Biosciences
microbiome
Allergan
AbbVie
M&A
Flag link:
In big year for microbiome drugs, a small biotech sets the bar
In big year for microbiome drugs, a small biotech sets the bar
BioPharma Dive
biotech
microbiome
Finch Therapeutics
C. difficile
Flag link:
Ferring’s gut microbiome drug clears phase 3 trial in C. diff
Ferring’s gut microbiome drug clears phase 3 trial in C. diff
Pharmaforum
Ferring Pharmaceuticals
clinical trials
microbiome
C. difficile
RBX2660
Flag link:
Heart Drugs May Influence Gut Microbiome In Obese People, Says New Study
Heart Drugs May Influence Gut Microbiome In Obese People, Says New Study
Forbes
microbiome
obesity
statins
Flag link:
Gilead to lean on Second Genome's microbiome work in $38M research pact
Gilead to lean on Second Genome's microbiome work in $38M research pact
BioPharma Dive
Gilead Sciences
Second Genome
microbiome
R&D
Flag link:
Kintai’s obesity drug that works via the gut microbiome moves closer to the clinic
Kintai’s obesity drug that works via the gut microbiome moves closer to the clinic
Fierce Biotech
microbiome
obesity
Kintai Therapeutics
Flag link:
Gut link to Parkinson's sparks talk of probiotic treatment strategy
Gut link to Parkinson's sparks talk of probiotic treatment strategy
Fierce Biotech
Parkinson's Disease
probiotics
microbiome
Flag link:
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
Xconomy
Novome Biotechnologies
microbiome
hyperoxaluria
Flag link:
Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs
Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs
Endpoints
uBiome
microbiome
M&A
Psomagen
JNJ
Pulmatrix
lung cancer
Flag link:
Treating multiple sclerosis with the help of the gut microbiome
Treating multiple sclerosis with the help of the gut microbiome
Fierce Biotech
Brigham and Women's
microbiome
microRNA
multiple sclerosis
MS
Flag link:
Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease
Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease
Endpoints
Takeda
Finch Therapeutics
microbiome
Crohn's Disease
Flag link:
France's Enterome Teams Up with Cancer Center to Validate Immunotherapy Candidate
France's Enterome Teams Up with Cancer Center to Validate Immunotherapy Candidate
BioSpace
Enterome
Memorial Sloan Kettering
microbiome
cancer immunotherapy
Flag link:
Thermo Fisher hooks gut onto its gene therapy pipeline, inks new collaboration pact
Thermo Fisher hooks gut onto its gene therapy pipeline, inks new collaboration pact
Endpoints
Thermofisher
gene therapy
microbiome
Arranta
Flag link:
Microbiome Report
Microbiome Report
CP Wire
microbiome
BiomX
LNC Therapeutics
Flag link:
Microbiome Report
microbiome
BiomX
LNC Therapeutics
Flag link:
Troubled poop-testing startup uBiome announces plans for liquidation
Troubled poop-testing startup uBiome announces plans for liquidation
Endpoints
uBiome
microbiome
bankruptcy
Flag link:
Will the Gut Microbiome Change Medicine? Wall Street Isn't Convinced.
Will the Gut Microbiome Change Medicine? Wall Street Isn't Convinced.
Motley Fool
microbiome
Flag link:
Microbiome Report
Microbiome Report
CP Wire
Azitra
LNC Therapeutics
Synlogic
microbiome
Flag link:
Bankrupt uBiome Says Founders May Have Misled Investors
Bankrupt uBiome Says Founders May Have Misled Investors
Xconomy
uBiome
microbiome
bankruptcy
Flag link:

Pages